Cargando…
Impact of Antipsychotic Use on Readmission Rates in Children and Adolescents With Autism Spectrum Disorder and Irritability
Background Risperidone and aripiprazole have been established as standard pharmacological treatments for irritability and associated aggressive behaviors in individuals with autism spectrum disorder (ASD), and are the only drugs approved by the United States Food and Drug Administration for those pu...
Autores principales: | Kompella, Sindhura, Vittori, Angela, Kroin, Jessica, Kaushal, Shivani, Khan, Sara, Neuhut, Samuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934570/ https://www.ncbi.nlm.nih.gov/pubmed/35321066 http://dx.doi.org/10.7759/cureus.22361 |
Ejemplares similares
-
Antipsychotics for irritability in children with Autism Spectrum Disorders
por: Muñoz Martinez, V., et al.
Publicado: (2022) -
Increased Readmission Rates in Younger Male Patients Due to Suicidal Risk in Newly Diagnosed Depressive Disorders After Initiation of Serotonin Reuptake Inhibitors
por: Pagan Colon, Ivan E, et al.
Publicado: (2022) -
A Retrospective Analysis on Risk Factors for 30-day Readmission Rates in Patients Living With HIV and Severe Major Depression Disorder
por: Kompella, Sindhura, et al.
Publicado: (2021) -
Hospitalization, Asthma Phenotypes, and Readmission Rates in Pre-school Asthma
por: Donath, Helena, et al.
Publicado: (2020) -
Food for Thought: Machine Learning in Autism Spectrum Disorder Screening of Infants
por: Siddiqui, Sohaib, et al.
Publicado: (2021)